• About us
  • Team
  • Privacy Policy
  • Contact
Thursday, November 19, 2026
  • Login
No Result
View All Result
World's first weekly chronicle of development news
  • Blitz Highlights
    • Special
    • Spotlight
    • Insight
    • Entertainment
    • Sports
  • Opinion
  • Legal
  • Perspective
  • Nation
    • East
    • West
    • North
    • South
  • Business & Economy
  • World
  • Hindi Edition
  • International Editions
    • Dubai
    • Tanzania
    • United Kingdom
    • USA
  • Blitz India Business
  • Blitz Highlights
    • Special
    • Spotlight
    • Insight
    • Entertainment
    • Sports
  • Opinion
  • Legal
  • Perspective
  • Nation
    • East
    • West
    • North
    • South
  • Business & Economy
  • World
  • Hindi Edition
  • International Editions
    • Dubai
    • Tanzania
    • United Kingdom
    • USA
  • Blitz India Business
No Result
View All Result
World's first weekly chronicle of development news
No Result
View All Result

Nod for Dengue vaccine

Qdenga cleared for individuals aged 4–60

by Blitz India Media
July 24, 2026
in Nation
0
Nod for Dengue vaccine

Blitz Bureau

NEW DELHI: In a significant step towards strengthening India’s fight against dengue, the Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation to the country’s first dengue vaccine, Qdenga®, for the prevention of dengue disease in individuals aged 4 to 60 years.

The vaccine, developed by Takeda GmbH, Germany, will be imported and marketed in India by Takeda Biopharmaceuticals India Pvt. Ltd. The approval has been granted by the CDSCO under the Ministry of Health and Family Welfare following a comprehensive scientific evaluation of its quality, safety and efficacy in accordance with the Drugs and Cosmetics Act, 1940, and the Drugs Rules, 1945.

Qdenga is a live, attenuated tetravalent dengue vaccine developed using recombinant DNA technology. It is manufactured in Vero cells using a dengue virus type-2 backbone engineered with serotype-specific surface proteins. The vaccine is supplied as a freeze-dried powder for reconstitution and is administered through a subcutaneous injection. The approved immunisation schedule consists of two doses of 0.5 ml each, to be administered three months apart.

The approval is backed by extensive global clinical evidence evaluating the vaccine’s safety, immunogenicity and efficacy across dengueendemic as well as non-endemic regions. Clinical studies involved participants from more than eight countries, including Brazil, Thailand and Sri Lanka. The evaluation also included a pivotal Phase III study conducted in India involving individuals aged 4 to 60 years.

Related Posts

SC Bars Mechanical Inclusion of Parents’ Salary in OBC Creamy Layer Test
Nation

Quota clarity

November 17, 2026
UGC equity norms
Nation

UGC equity norms: Centre may form review panel

November 17, 2026
India Growth
Nation

Metro boom

November 17, 2026
Responsible media reporting essential
Nation

Responsible media reporting essential

November 17, 2026
India’s Poverty Decline Reflects Changing Living Standards
Nation

A Changing India

November 17, 2026
signals-of-change-road-safety-india-book-review
Nation

Not just signals and sensors; it’s people

November 17, 2026
Load More
Next Post
Strengthening

Strengthening coastal defence capabilities

Recent News

India-Japan Defence Cooperation
News

India, Japan reaffirm commitment to free, open and rules-based Indo-Pacific

by Blitz India Media
November 19, 2026
0

Blitz BureauTokyo, 19 November: India and Japan held a 2+2 Ministerial Dialogue in Tokyo, reaffirming their Special Strategic and Global...

Read moreDetails
Indian stock market

Sensex jumps 990 points, Nifty reclaims 25,500 as auto stocks power rally

November 19, 2026
Blitz BureauNew Delhi, 19 November: Former wicketkeeper Ian Healy believes Pat Cummins does not need to stand down as Australia’s Test captain, but he has lost a big part of his credibility following Cameron Bancroft’s fresh claims on the 2018 ball-tampering scandal. Healy’s comments come after Bancroft claimed that the entire side knew about the plan to use sandpaper during the Cape Town Test against South Africa, and that he ‘took the bullet’ for the group. That revelation has turned the spotlight back on Cummins, who was one of the bowlers on that team and who previously said at a press conference last week that they were unaware of the plot. “No, he doesn't need to stand down. And I don't want to get into another panic mode of what happened in 2018, it was panic, and they tried to do an investigation in no time, didn't talk to anyone, it was rubbish. It was a lack of quality and rubbish, and rushed, and panicked. “Now, I can't say whether he should stand down now. Will he stand down? That might be a different thing. He might stand down. I would feel without refuting Cameron Bancroft's words again, he will struggle to captain the team. You've had a big part of your credibility taken away with that press conference now that it's been proven to be not as complete as Pat made it out to be,” Healy told SEN Radio. As per Healy, the hit to the credibility also extends to Cummins fellow bowlers from that series: Josh Hazlewood, Mitchell Starc and Nathan Lyon. “I would say it taints their personal legacies. I don't think it's going to taint their performance legacies. “Either side of this period where there was ball tampering happening - how long was it going before South Africa and probably not much since - but they got very brazen with it, so that tells me it's probably been going on longer than we think. “So they probably achieved some success with their skills, with a ball that's doing more than it was going to. That's a little bit of a part of their career legacy. Performance legacy, no. I think their performances stack up ok to what all the cricket world have been doing. Personally now, they're not as credible as they once were, unless they change something drastically in the next few days.”

Cummins has lost a big part of his credibility, says Healy

November 19, 2026
modi

PM Modi challenges India Inc to raise quality standards

November 19, 2026
India, Italy to strengthen economic partnership

India, Italy to strengthen economic partnership: Goyal

November 18, 2026

Blitz Highlights

  • Special
  • Spotlight
  • Insight
  • Entertainment
  • Health

International Editions

  • US (New York)
  • UK (London)
  • Middle East (Dubai)
  • Tanzania (Africa)

Nation

  • East
  • West
  • South
  • North
  • Hindi Edition

E-paper

  • India
  • Hindi E-paper
  • Dubai E-Paper
  • USA E-Paper
  • UK-Epaper
  • Tanzania E-paper

Useful Links

  • About us
  • Team
  • Privacy Policy
  • Contact

©2024 Blitz India Media -Building A New Nation

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

    No Result
    View All Result
    • Blitz Highlights
      • Special
      • Spotlight
      • Insight
      • Entertainment
      • Sports
    • Opinion
    • Legal
    • Perspective
    • Nation
      • East
      • West
      • North
      • South
    • Business & Economy
    • World
    • Hindi Edition
    • International Editions
      • Dubai
      • Tanzania
      • United Kingdom
      • USA
    • Blitz India Business

    ©2024 Blitz India Media -Building A New Nation